Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
A novel anti-CD40 monoclonal antibody, iscalimab, for control of Graves hyperthyroidism-a proof-of-concept trial
Using predictive data, P4 medicine [88] can guide lifestyle changes and tailor treatments to each patients genetic background, environment, medication response, and disease course
Widmarks foundational research in the 1920s and refined through decades of forensic toxicology study, reflect the average difference in body water content between the two sexes
This helps patients establish regular eating patterns and increase nutritional intake
US$ 22.98
US$ 27.61
US$ 28.91
US$ 25.68
US$ 29.86
US$ 21.94
